Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat

Abstract Stress activates the hypothalamo–pituitary–adrenal (HPA) axis, regulates the expression of brain-derived neurotrophic factor (BDNF) in the brain, and mediates mood. Antidepressants alleviate stress and up-regulate BDNF gene expression. In this study, we investigated the effect of chronic un...

Full description

Saved in:
Bibliographic Details
Published inBrain research Vol. 1366; pp. 141 - 148
Main Authors Zhang, Yang, Gu, Fenghua, Chen, Jia, Dong, Wenxin
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 17.12.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Stress activates the hypothalamo–pituitary–adrenal (HPA) axis, regulates the expression of brain-derived neurotrophic factor (BDNF) in the brain, and mediates mood. Antidepressants alleviate stress and up-regulate BDNF gene expression. In this study, we investigated the effect of chronic unpredictable mild stress (CUMS) and the different kinds of antidepressant treatments on the HPA axis and the BDNF expression in the rat brain. Adult Wistar male rats were exposed to a six-week CUMS procedure and received different antidepressant treatments including venlafaxine, mirtazapine, and fluoxetine. Immunohistochemistry and real-time PCR were used to measure BDNF expression levels in the rat brain, and ELISAs were used to investigate the plasma corticosterone (CORT) and adrenocorticotropic hormone (ACTH) levels. CUMS significantly decreased the BDNF protein level in the DG, CA1, and CA3 of the hippocampus and increased plasma CORT level. Chronic antidepressant treatments all significantly increased BDNF protein levels in the hippocampus and the pre-frontal cortex. In addition, venlafaxine and mirtazapine inhibited the increase of plasma CORT level. These results suggested that an increase in the BDNF level in the brain could be a pivotal mechanism of various antidepressants to exert their therapeutic effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0006-8993
1872-6240
DOI:10.1016/j.brainres.2010.09.095